Table 2.
Compound | Pharmacological activities | Mechanisms of action | Reference |
---|---|---|---|
Glycyrrhizic acid | Anti-inflammatory antiviral inhibition of hepatic fibrosis |
Regulating the expression of inflammation-related factors; inhibition replication of viral mRNA |
[46–49] [51, 59] [45] |
| |||
Compound glycyrrhizin tablet | Improving the liver dysfunction augmented the entire cytotoxic function mediated by hepatic lymphocytes inhibiting the cascade leading to apoptosis |
Regulating the expression of inflammation-related factors; promoting the growth of hepatocyte; inhibition replication of viral mRNA |
[60] [61] [62] |
| |||
Glycyrrhetinic acid | Anti-inflammatory antiviral antiallergic antitumor proliferation |
Regulating the expression of inflammation-related factors; inhibition replication of viral; inhibition of the expression of sensitizing factors and tumor-associated factor; |
[63] [64] [65] [66] |
| |||
18β-glycyrrhetic acid | Antiviral anti-inflammatory |
Regulating the expression of inflammation-related factors; inhibition replication of viral mRNA |
[67] |
| |||
Diammonium glycyrrhizinate | Anti-inflammatory, resistance to biologic oxidation and membranous protection neuroprotective effect |
Regulating the expression of inflammation-related factors; regulating the enzymatic reactions' related oxidation |
[68] |
| |||
Dipotassium glycyrrhizinate | Anti-inflammatory | Regulating the expression of inflammation-related factors | [69] |